Literature DB >> 30967645

Fulvestrant enables better outcomes.

Peter Sidaway1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30967645     DOI： 10.1038/s41571-019-0211-7

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

Review 1.  Establishing peripheral PD-L1 as a prognostic marker in hepatocellular carcinoma patients: how long will it come true?

Authors:  D-W Sun; L An; H-Y Huang; X-D Sun; G-Y Lv
Journal:  Clin Transl Oncol       Date:  2020-05-27       Impact factor: 3.405

2.  Rethinking the combination treatment of fulvestrant and anastrozole for metastatic breast cancer: an integrated reanalysis of aromatase-estrogen receptor axis.

Authors:  Xing Huang
Journal:  Clin Transl Med       Date:  2019-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.